Plasma proteomics of critical COVID-19 patients and the effect of imatinib treatment - Milan 2023

COVID-19: diagnosis and treatments

Chair(s): Tony De Soyza, Gareth Hynes

Session type: Oral presentation

Plasma proteomics of critical COVID-19 patients and the effect of imatinib treatment

Erik Duijvelaar

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - INNA-051 prophylaxis enhances innate immune responses confirming accelerated viral clearnace in a human influenza challenge model.

Francesca Mercuri

Replay

Poster

Abstract

Slides

The impact of the COVID-19 pandemic in deaths due to respiratory diseases: A comparative analysis of 2021 and 2020 vs background rates in 2019 in Spain

Joan B Soriano

Replay

Poster

Abstract

Slides

LSC - 2023 - Longitudinal proteomic profiling reveals early onset increase in collagens and (auto-)antibodies in COVID-19 patients

Anna Semenova

Replay

Poster

Abstract

Slides

Diagnosis of COVID-19 with enhanced real-time mass spectrometry breath analysis

Stanislas Grassin Delyle

Replay

Abstract

Slides

Abnormal immune response in patients with persistent lung sequelae after COVID-19

Tamara Cruz Santa Cruz

Replay

Poster

Abstract

Slides

Plasma proteomics of critical COVID-19 patients and the effect of imatinib treatment

Erik Duijvelaar

Replay

Poster

Abstract

Slides

Expression patterns of Interleukin-33 and its receptor ST2 in severe COVID-19

Caroline Lindo

Replay

Poster

Abstract

Slides

DIURNAL RHYTHMS IN COVID-19 VACCINE EFFICACY

Guy Hazan

Replay

Poster

Abstract

Slides

Post-Hospitalisation COVID-19 (PHOSP-COVID): a prospective multi-centre UK cohort study

Omer Elneima

Replay

Poster

Abstract

Slides

Subtle Pulse Electro-biological Recovery Apparatus (SPERA) as anti-inflammatory treatment for COVID-19 A Proof of Concept Study

Stefan-marian Frent

Replay

Poster

Abstract

Slides

Discussion and Q&A

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}